Is Potassium iodide registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 4 valid registrations of Potassium iodide, including TERODA (130 mg, Tablet, SAR 17.10); TERODA (65 mg, Tablet, SAR 8.55).

Is Potassium iodide approved by the US FDA?

Drugs@FDA lists 6 application product lines for Potassium iodide, including IOSAT (Over-the-counter); THYROSAFE (Over-the-counter); POTASSIUM IODIDE (Over-the-counter); THYRO-BLOCK (Discontinued); POTASSIUM IODIDE (Discontinued).

Is Potassium iodide on the WHO Model List of Essential Medicines?

Yes — 18.7. Thyroid hormones and antithyroid medicines (core (EML); complementary (EMLc) list): Thyrotoxicosis.

Active substance

Potassium iodide

SFDA 4
US FDA 6
WHO EML 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
TERODA	130 mg	Tablet · Oral use	10 Blister	SAR 17.10	Generic · Prescription	SPIMACO	Valid
TERODA	65 mg	Tablet · Oral use	10 Blister	SAR 8.55	Generic · Prescription	SPIMACO ADDWAEIH	Valid
TERODA	65 mg	Tablet · Oral use	100 Blister	SAR 85.50	Generic · Prescription	SPIMACO	Valid
TERODA	130 mg	Tablet · Oral use	100 Blister	SAR 171.00	Generic · Prescription	SPIMACO	Valid

Indications — CHI Daman Drug Formulary

HYPERTHYROIDISM

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
IOSAT	130MG; 65MG	tablet · oral	ANBEX	Over-the-counter	14 Oct 1982
THYROSAFE	65MG; 130MG	tablet · oral	BTG INTL	Over-the-counter	10 Sep 2002
POTASSIUM IODIDE	65MG/ML	solution · oral	MISSION PHARMACAL	Over-the-counter	24 Mar 2016
THYRO-BLOCK	130MG	tablet · oral	MEDA PHARMS	Discontinued	9 Nov 1979
POTASSIUM IODIDE	1GM/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	solution · oral	ROXANE	Discontinued	19 Feb 1982
THYROSHIELD	65MG/ML	solution · oral	ARCO PHARMS LLC	Discontinued	12 Jan 2005

WHO WHO Model List of Essential Medicines (2025)

18.7. Thyroid hormones and antithyroid medicines · core (EML); complementary (EMLc)
Thyrotoxicosis
Oral > Solid > tablet: 65 mg (scored)
6.3. Antifungal medicines · complementary
Sporotrichosis
Local > Topical > Solution: Saturated solution

Combinations containing Potassium iodide

Hamamelis extract + ichthyol + potassium iodide

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.